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Economic Issues In Development of Sustainable
Animal Health Follcles*
Animal health concerns are not new to agriculture. Animal health
breakthroughs have been occurring with regularity. They represent an advancement
in technology. Likewise, the need for evaluation of technologies is not new.
While animal health represents an arena where some dramatic new discoveries are
likely, approaches for their evaluation and effective implementation into
American agriculture will likely Include standard tools now available. This
would involve tools such as budgeting, cash flow analysis, systems simulation
analysis, and welfare analysis to measure benefits from improved animal health
or disease control.
DISEASE CONTROL BENEFITS
Animal health or disease control benefits can be quite diversified and
far ranging. They range from producers, to consumers, to agri-business, and
government agencies. Producers gain from factors such as reduced animal
mortality levels. Disease can also have an adverse impact on production
efficiency. Factors such as feed efficiency, reproductive levels, rate of gain,
labor efficiency, and treatment and medication costs are examples of production
efficiencies impacted. Producers can also benefit from reduced use of disease
control compounds. Probability of self inoculation etc. could be lessened.
Disease control can reduce production variability leading to a more uniform
product and more consistent marketing times. Producer harm from farm originated
infections may also be lessened. Levels of animal or animal product condemnation
too would be lessened.
Improved control of diseases which are livestock specific could lead to
benefits to selected producers through consumer product substitutions. Demand
fcxor
may expand duSe'to greater consumer confidence in the jproduct from the Improved
perception of a more "wholesome" product;
Agri-businesses too can benefit from improved animal disease control.
Meat packers and processors would have a more uniform product (raw material) of
hi^er quality. They would need less time for sorting, handling, and disposing
of damaged or condemned products. Health risks for meat inspectors, meat
packers, and practitioners would be lessened. Demand for animal health
consulting services too would likely increase as a necessary component for
effective adoption of the health management strategies.
Reduction in animal disease would lead to an increased efficiency and
reduction in the level of animal health regulatory function. Inspectors too
would be subjected to a reduced exposure to zoonotic diseases.
Consumers benefit from improved animal disease control through cheaper
prices for meat and animal products. Reduced animal disease would also lead to
lower levels of compound use and reduced levels of drug resistance and residues
in the food chain. Higher quality and more wholesome products would be
available. Risks of sudden changes in product availability would be lessened
through reduction in the level and occurrence of catastrophic disease. Benefits
could also accrue from reduced probability of harm from farm-originated
infections and disease.
COHSUHERS AND DISEASE CONTROL
Some of the benefits of disease control in production livestock were
discussed in the previous section. Consumers clearly benefit from animals which
are produced at lower costs with resulting lower market prices. The particular
methods used to control disease in animals may, however, influence consumer
satisfaction with the product and their overall consumption patterns. Consumers
3are concerned with at least the four following aspects of disease control and
product quality: safety of the product as to natural disease characteristics
(lack of bacterial Infections, zoonotlc disease etc.)* safety of the product
as to compounds added or techniques used during production or marketing (use of
known carcinogens etc.)> humane or Inhumane treatment of animals during the
production process, and the effects of the disease control methods used on the
environment. Disease control methods developed through biotechnology may be of
particular concern In relation to these control factors.
Improved control methods usually reduce the likelihood of natural disease
problems and create a positive product Image. Consumers are more likely to buy
a product they perceive Is free from disease or contamination. For example,
consumers are more likely to buy poultry products they are certain are free from
salmonella.
While disease control techniques Improve product quality as far as organism
levels, they may Introduce compounds that create as much consumer concern as the
original disease organisms. For example, meat preservatives may have the
potential to be carcinogenic. Consumers may be concerned about the safety of
meat from animals treated with growth hormones o^ food additives. They may be
particularly wary of the safety of products developed through gene splicing
techniques. Despite rigorous testing and careful procedures, consumers may still
react negatively to products created using "new" techniques. Despite education
programs, the Idea of mutant horrors Is still on the consumer mind. Some
consumers may react negatively to transgenlc animals due to moral or ethical
beliefs. Even though researchers find no serlotis ethical Issues In altering
natural processes some consumers may be opposed to such techniques and not
purchase products so produced.
4Consumers may also be concerned about any physical discomforts caused to
producing animals due to the use of implants, hormone treatments etc. While
these factors are non-economic in character, they become economic because they
affect the consumer's perception of quality or acceptability and therefore the
price they are willing to pay.
Individual consumers may be concerned about the effects that disease
control measures have on the environment. For example, consumers may be
concerned about antibiotics' in feed and the effects of residue levels in the
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environment. These residue levels may lead to problems of compound resistance
etc. Whether such effects are actually significant or not does not change
consumer reaction if consumers believe them to be important. Consumers may
react to perceived environmental problems by boycotting products or attempting
to alter regulations on the products use. While such external effects on any
one consumer may be small, such effects may be large in aggregate so that even
if consumers are not moved to act to control these problems, they are still a
problem for the health of society as a whole. Socially optimal control measures
must take into account these external effects and are discussed in the next
section.
EXTERNALITIES IN DISEASE CONTROL
Externalities An externality is defined as an action by one individual that
affects the level of well-being of another individual where the first individual
does not take into account this effect in his decision-making. Externalities
can be both positive and negative. For example, a person polluting a stream does
not usually consider the effects on downstream individuals of the perceived
inexpensive method of waste handling.
There are many examples of externalities in animal disease control. A
5fanner who eliminates pseudorables from the swine herd reduces the probability
that the neighboring swine or cattle herds may receive the virus. Packers
allowing crushed bone in ground meats create a hazard for consumers. When a
pork producer allows sulfa residues to be spread in the environment through
improper feeding and handling procedures, he may create a health hazard either
directly or through the cumulative effects of compound resistance. Such compound
resistance will be discussed in a later section. When a cattle producer allows
infectious waste to flow into the groundwater he is creating an externality for
other users. When a farmer erodes the soil because the production effects won't
be felt until far in the future he is imposing an externality on future
generations.
With reference to disease control It is clear from the examples that
externalities are of two types: externalities created by the spread of disease
mechanisms and externalities created by the agents used to control disease.
Society must deal with these off-site effects of disease control or non-control
in determining optimal resource allocation.
Externalities and Sustainable Agriculture Sustainable agriculture is defined
as the development and promotion of systems which promote responsible natural
resource stewardship and long term farm profitability. Externalities are
intimately related to natural resource use since many natural resources such as
flowing water, air, and a disease free environment do not have clear property
ri^ts. Because property rights are not exclusive for many resources,
externalities develop because producers do not consider the effects of their
actions on these unseen property owners. Unseen owners in this context are the
members of society at large and in future generations who will eventually reap
the benefits or costs of current natural resource use. Sustainable systems are
6those that can remain profitable through time by the careful use and management
of resources. When externalities are internalized in the decision making
process, the resources of society are optimally used for everyone concerned.
Externalities can be internalized in a variety of ways. The most common ways
are through quantity and pricing regulations or changes in ownership patterns.
An example of a quantity regulation is the banning of a particular chemical while
a tax on use is a pricing method of control. Ownership can be changes through
legal means such as giving a down stream firm the legal ri^t to clean water.
Animal disease control measures can create externalities in several ways.
Animal disease control in conjunction with sustainable agricultural systems can
create additional externalities and problems of regulation. The reduced use of
animal health products due to genetically improved animals may reduce some
externalities due to chemical residues. Alternatively, the use of animal wastes
as fertilizer in a sustainable system may increase dangers of groundwater
contamination. The use of genetically engineered vaccines may help eliminate
some diseases and thus improve the overall environment. Such vaccines may,
however, discourage good management practices and increase the disease reservoir
in the environment as animals do not show clinical signs but still carry the
disease. Improved diagnostic tests may reduce the need for prophylactic
treatment and the use of environment damaging chemicals but they may also
encourage more treatment as the extent of the disease is apparent. Sustainable
systems may also emphasize the control of disease through the proper handling
and treatment of waste materials. There are no clear answers as to the effects
of new disease control agents on the environment but sound research should
consider the external as well as the internal effects in carrying out benefit-
cost analyses for new and improved products.
7COMPOUND RESISTANCE
One of the problems in the treatment of animal disease using chemical
compounds is that organisms may become resistant to the compounds over time.
Furthermore the use of a particular chemical may destroy beneficial and well as
harmful organisms. The effects of chemical use on future immunity ^must be
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balanced against the benefits of current use. Biotechnology offers an
opporttinity to reduce compound resistance by reducing the need for chemical
control through new and improved genetic material that may be disease resistant.
Naturally immune animals may be more sustainable than those dependent on chemical
control. Unforttmately, animals immune to one disease may be more susceptible
to other diseases. Sustainability then means the use of compounds that do
significantly reduce future profitability and environmental preservation.
BIOTECHNOLOGY AND ANIMAL DISEASE CONTROL ADOPTION ISSUES
The decision on adoption of animal disease control technologies will
involve producer evaluation of a number of factors. Similarly, adoption and
sharing of benefits will not likely be uniform across all producers. Nor will
they necessarily be uniform by t3rpe and size of operation. Factors which will
influence level of success in adoption will include such forces as management
Intensity, information availability, financing, production systems, and available
resources.
Improved Management Effective and economic use of many animal health products
will increase the need for improved production management. Some technologies
will be complex requiring a clear understanding of animal biology and all the
integrated production relationships. Information on disease population dynamics
and epidemiology will be needed. Intense production management skills will be
necessary to effectively integrate all factors. Health management strategies
8may mandate adjustments in production strategies. These In turn will likely
Improve production and/or cost efficiencies. These Impacts need to be compared
to the value of Increased production keeping In mind demand and supply
elasticities and resultant market effects.
Technological advancements, animal health Included, will further Increase
the need for good records. These Improvements will magnify the need for
effective and Intensive management. Managers will need records to aid In
management decisions. Knowledge of production levels and changes In production
levels as a result of animal health changes Is needed. For this, baseline data
are needed when evaluating cost effective animal health management decisions.
Operations with subpar management may gain little from adoption of animal health
management strategies. Those with top level management will be In position to
make needed adjustments to effectively utilize the technologies.
Animal health strategies are not necessarily products that will make a
below average manager an above average manager. To the contrary they may likely
magnify and expand the differences. Management and production Intensity needs
to be present for effective and economic Infusion Into the operation before
adoption of these Innovations. The management capacity of below average managers
will In particular need Improvement for effective animal health product
utilization. The premium for top level management will grow.
Relatively large and specialized farm operations have effectively
streamlined the process of gathering Information and management expertise. They
are highly specialized, in comparison, a typical producer may have from two to
six or even more enterprises. This Is a situation where It Is difficult to stay
abreast of all the enterprises. Staying current on new animal health management
and other Interacting forces Is a difficult task.
9Programs aimed at development of and nurturing Intensive management are
needed. Management effectiveness will be a dominant variable In successful
adoption. Development of effective interrelationships between public and private
firms to enhance management is needed. Thought is needed on how this can be best
accomplished. To be successful management Intensity is needed before adoption
of the new technological products.
Development of management strategies necessary for successful adoption of
animal health strategies Is' also needed. As the competition for development of
new and successful products continues, sight of management strategy development
must not be lost. Successful adoption is needed if the product is viable
economically. For this, producers need information on management strategies and
systems necessary for use of the product. Development of this information may
eliminate much trial and error in the adoption process.
Information An important issue Is that^ of methods of and responsibility for
distributing product information to producers. What are the Interrelationships
between the private and public sector? It seems that a combination of each is
needed. However, this effective combination is open to much debate. The demand
for consulting service activities will likely increase. Animal health products
will Increase the diversity and complexity of issues already facing farm
operators. It will be very difficult for operators to remain current on all
factors impacting all enterprises on the operation. Only the highly specialized
and large operations will be able to internalize the information base. Others
will need to effectively and efficiently Incorporate some of this information
base from outside sources.
Financial Some strategies may require that the financial position of the
business along with available business management skills be In a good position.
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Successful adoption will be much more likely for operations with these forces
in place. Some products will introduce a level of instability into the industry
over the adoption and adjustment process. Top level business management skills
will be needed to effectively manage this Instability. Moreover, effective use
may necessitate a particular environment only accomplished through remodeling
and investment in production facilities. Survival will be difficult for those
in a weak financial position.
An important decision variable is that of production and income
variability. Evaluation of the impact of the animal health product on production
variability is needed. Some strategies will reduce variability while others will
increase variability. Some which increase expected production levels may also
increase production variability. Returns can be impacted similarly. Adoption
will depend upon the risk aversion of the producer and her/his ability to absorb
the potential increased risk levels. The new health management strategies may
perform very well when all production factors perform as needed and in unison.
However, if one of the factors is out of sync, production may be dramatically
reduced. This further amplifies the increased pressure for intensive management
as management can impact the degree of production (return) variability.
The upfront or fixed cost of animal health products and its effective
adoption is an important consideration. Products which have high upfront costs
for factors such as information and knowledge gathering, purchase fees, set up
etc., can have impacts dependent upon farm size. There may be "lumpy" inputs.
Large farms may be able to economically incorporate their use while it would be
cost prohibitive for smaller operators. Smaller producers may need to rely on
outside expertise and advise for effective incorporation of the product.
Resource Quality Animal health products may require an improved quality of
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resources to accompany their use. Products may be more effective In certain
types of production systems. The production environment may be highly related
to product effectiveness.
Specialized Product Some animal health products may lead to production of a
specialized product. Examples may include drug or residue free products. The
need for effective marketing to take advantage of any product premiums would be
increased. This too may require product identification from producer to
(
consumer. Open markets typically do not handle identification and separation
of specialty products well. The need for marketing techniques such as production
and/or marketing contracts may evolve for this tjrpe of product.
The availability of animal health strategies will not alter the success
formula for farming. The key to success is and will be, first and foremost,
good and effective management. For some products the importance of this success
formula will be magnified. Without it probabilities of firm survival will be
lessened. It should also be realized that animal health products can have an
impact on farm size and effective operating level. Some are more size neutral
than others. However few, if any, are completely size neutral. At a minimum
there is time for information gathering etc. on the strategy that would not vary
dramatically by farm size. Some may have a start-up or purchase fee for its use
which is not voliune related. Thus, larger operators will have an inherent
advantage over smaller operators. None-the-less operations which are intensively
managed will survive and will remain a sustainable part of the respective
industries.
ANIHAL DISEASE IHHUNITY AND SUSTAINABLE AGRICULTURE
Sustainability has at least two parts: environmentally sustainable and
economically sustainable. Improved animal disease immunity or resistance has
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tremendous potential on both fronts. It has the potential for Improved
profitability and enhancing the environment and creating a more sustainable
agriculture.
Animal health Is tied to animal genetics and the animals Immune response
to disease. It has been shown that the major hlstocompatlblllty complex (MHC)
has an Influence on the animals Immune response and disease resistance (Dorf,
1981). For example, It has also been shown that economic traits of chickens such
as liability, feed efficiency, egg production, fertilization rate, hatchablllty
and growth rate are also associated with MHC (Bacon, 1987). Lamont points to
reasons for selecting for genetic resistance to disease (Lamont, 1989). Genetic
resistance can lead to reduced use of vaccinations and other products and
associated costs. It leads to Improved disease resistance and It offers
Increased protection as vaccinations lose effectiveness as a result of viral
Irritation. She concludes that potential exists for improving production
efficiency and animal health through work with the MHC through both conventional
breeding and genetic engineering.
These potential breakthroughs can provide large economic benefits across
society. Livestock producers gain production efficiencies and reduced
reoccurring health maintenance expenditures. The net Impact Is not known
however. Products developed through genetic engineering will likely demand a
premium price to obtain the genetics. The method of genetic availability and
associated produce costs remain with a high degree of uncertainty. Reduced
reliance on use of compounds for disease control can dramatically reduce the
problem of viral mutation and the need for still other compounds. Development
of the image of a "wholesome" product would be easier through national immunity.
Constimers would benefit through lower levels of, or possibly even elimination
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of, restricted compounds showing up In the food chain.
It must be remembered that production traits can be positively or
negatively associated with disease resistance. Govora and Spencer have Indicated
that It Is feasible to Improve disease resistance and selected production traits
(Govora, 1983). However, disease resistance is typically disease specific.
Information on positive and negative relationships are needed. The economics
of a positive relationship are typically greater than negative relationships.
However, this depends upon disease and the production trait with a negative
relationship.
DISEASE CONTROL METHODS
Basic methods of disease control would Include; medication, vaccination,
eradication, and genetic resistance or natural Immunity. In some slttiatlons
medication, and/or vaccination may be low cost and highly effective. This may
appear to be an easy and highly economic decision. For others, herd condemnation
with mandatory slau^ter may be felt to be quite effective and economic.
Uhen evaluating disease control and/or prevention programs attention should
be given to the programs Impact on the breeding herd. What may appear to be very
economic and highly effective may be a short run phenomena. Evaluation over the
larger run may lead to different conclusions. For example, herd replacements
tend to be selected from those lines which perform best under the disease
management strategies in use. These may be animals which perform best under
vaccination, medication, and eradication programs. This can reduce the
expression of disease resistance (Govora, 1963). A population is selected that
performs well under heavy disease control product use. But, it may also be a
population that doesn't perform well if the products were to be withdrawn from
the market.
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Eradication programs have been successful for some diseases. However,
these tend to be costly. One method of eradication is that of depopulation or
whole herd slau^ter. Economic studies have shown this may be costly. However,
a major cost of this approach has been overlooked by all economic studies to
date. That is the economic value of herd members which are naturally immune to
the disease. These could be used to build a replacement herd for disease
resistance. iThe long term economic value of these animals may be quite high.
The old adage may apply "are we throwing the baby out with the bathwater?"
Mandatory slaughter of breeding livestock may also be eradicating those animals
which are immune while using multiplier animals which are not immune (Warner,
1987).
Screening animals for disease resistance may be an avenue for large
economic and societal benefits. This would include such areas as genetic
screening, serological tests, diagnostic tests.
CONTROL COST CASE STUDIES
National Animal Health Monitoring System Studies A National Animal Health
Monitoring System (NAHMS) pilot study conducted at Ohio State University
estimated annual dairy disease costs at $163 per cow. This included nearly $28
for drugs, biological and veterinary services (Miller, 1987). Lost milk
production was estimated at $33 per cow. The University of Missouri farm
business dairy results showed an average per cow cost of $40 in 1985 and $41 in
1986 for drugs and veterinary services. (Bennett, 1986, 1987). The Missouri
data also pointed out wide fluctuations in these costs exist from farm to farm.
The percentage of herds and animals in the Iowa NAHMS pilot study which
had positive titters for selected diseases is shown below In Table 1. While many
of the herds had antibodies to several disease agents, little is known about what
15
disease Is costing producers In the form of reduced productive efficiency, death
loss, etc.
The Iowa State NAHMS pilot study on swine estimated disease costs at
$12,034 per farm (Owen, 1987). Annual per farm estimates ranged from $406 to
$54,358. Such a large range reflects varying size of operations as well as
varying effectiveness of management. Monthly costs per sow ranged from a low
of $1.50 to a high of $41.80. Annual disease costs averaged $8.40 per head of
slaughter animal. Primary losses occurred from pneumonia ($1.26), stillbirth
($0..87), salmonellosls ($0.47), diarrhea ($0.47) and hemophllus $0.33 (Owen,
1988). These losses represent observable losses and are likely an underestimate.
Losses such as reduced weight gain, reduced litter size, etc., typically go
unnoticed and are not considered. For some diseases these losses may be large.
The major disease cost Item was that termed as "animal loss" or primary
death loss. At $4.96 per head of slaughter animal It represented 59% of reported
disease costs ($8.40 per head of slaughter animals). The major costs from animal
disease are not disease prevention or treatment costs but losses from death,
reduced animal production efficiency, etc. Therefore, greater efforts are needed
In establishment of methods to measure reduced animal productivity. Variables
currently receiving focus are overlooking some of these significant disease
costs.
Fseudorables Analysis Pseudorables (Aujesky's disease) Is a disease of swine
with a long history in the United States. Beginning In the 1970's, pseudorables
began to be recognized as a major contributor to large losses In swine herds.
Because of the Increased severity of the disease there has been a strong effort
to better understand the disease, develop improved methods of control, better
vaccines and diagnostic tests, and analyze the benefits and costs of eradication
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versus herd by herd control without eradication. In 1984 a pilot project was
begun in Marshall County, Iowa with the Intent of eradicating the disease from
the county. The project also investigated the costs of three alternative
eradication procedures. By using data collected from positive herds, the costs
of pseudorabies outbreaks was also measured. Some of the more interesting
results are discussed here as examples of methods used in the economic analysis
of disease control.
Using a pilot project data Hallam, Zimmerman and Beran evaluated PRV costs
and associated cleanup costs. The cost per instance of a clinical sign are
reported in Table 2. These losses were then multiplied by occurrence
probabilities to determine the expected loss from a PRV outbreak. Occurrence
probabilities also came from the sample data. These losses are reported in
Table 3. They ranged from $20 to $40 per sow depending on assumptions used.
They imply that the typical 100 sow herd would differ by sum of $2,000 to $4,000
from an outbreak.
The costs of eliminating pseudorabies from twenty three swine herds in
Marshall County, Iowa were also estimated using Pilot Project data. Herds
cleaning up used depopulation-repopulation methods, test and removal methods
and a program of controlled vaccination with offspring segregation. The details
of these plans are discussed in Zimmerman et. al. 1989. The results are
summarized in Table 4. The most expensive plan was depopulation with a per sow
in the herd cost of $204. The most economical plan was test and removal with
a cost of $7.79. The most commonly used plan of offspring segregation had a per
sow cost of $40.84. While test and removal was very inexpensive it is only
appropriate when prevalence within the herd is very low. These rather large
costs of the cleanup, when compared with the costs of an outbreak. Imply that
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few infected herds will have an incentive to eliminate the disease from their
herds unless they caxmot vaccinate and have a high probability of future clinical
signs. This is yet another example of the importance of externalities in animal
disease control. The infected producer may rationally decide to live with PRV
and not eliminate the disease since the costs of cleanup exceed the expected
costs due to future outbreaks. However the producer does not consider the
effects of this decision on the probability of his neighbor's herd contracting
(
the virus. This implies that eradication efforts will need the cooperation and
financial support of many producers and or the government.
A study of a large swine production operation in North Carolina estimated
pseudorabies virus (PRV) losses at $16.21 per sow farrowed (Kliebenstein, et al,
1988). Losses ran for 17 weeks after the outbreak and amoimted to 5.28% of pigs
born during the outbreak period. This same study showed losses from "hi^ loss"
disease (primarily transmissible gastroenteritis) to be 14.04% of pigs born.
The outbreak periods ran from one to four weeks. Respiratory diseases reduced
production levels by approximately 9%. Length of this form of disease was quite
variable. With the assumption of 7.8 pigs (U.S. average) per sow per litter,
PRV cost per pig was $2.09 for that swine operation. The Iowa NAHMS study showed
7% of the hogs had positive titters for PRV (Owen, 1987). Extrapolating to a
national scale, if 7% of the 80 million market hogs produced annually are
infected with PRV, it means 5.6 million are infected. If this is true and if
losses associated with PRV were to be reduced by half, the cost saving would be
approximately $5.9 million annually (5.6/2 x $2.09).
Using data from the Iowa Pilot Project and other surveys a benefit cost
analysis of a national eradication program was completed (Hallam et. al. 1987).
The analysis considered the costs and benefits of a ten year eradication plan.
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States were assumed to follow different protocols depending on disease severity.
The benefits of eradication Included eliminated clinical disease and vaccination
and reduced testing costs. Non-clinical disease costs were not included since
data was not available or of questionable quality. The discounted value of these
benefits was determined to be $136.4 million using a 10% discount rate and $271.5
million using a 6% discount rate. The total costs of the program to producers
and government were $134.4 million using a 10% rate and $155.8 million using a
6% rate. The benefit cost ratio was not large but the program has been
undertaken.
Swine Slaughter Check and Panel A Missouri swine panel study showed direct
swine health expenditures ranging from $0.59 to $2.59 per pig (Kliebenstein, et
al, 1983). Total confinement and mixed housing systems tended to have higher
per-plg expenses. The two leading expense items were for pneumonia and atrophic
rhinitis prevention and control. This range in health expenditure cost is
consistent but narrower than that shown in the Iowa State NAHMS report. The
Missouri study showed that the primary disease seasons were the fall and winter
quarters. During the winter quarter, 48% of the hogs were reported to have some
form of health problem. This was 40% during the fall and 31.5% for the year.
A slaughter check study showed the two primary morbidity events in swine
were pneumonia and atrophic rhinitis (AR) (Boessen et al, 1988). Losses from
pneumonia for a "batch" producer averaged $1.09 per hog. For a continuous
producer, losses averaged 1.5 cents per hog per day or $5.48 per hog production
space per year. Losses from AR were $0.95 per hog in a "batch" production
system. It was 1.3 cents per hog per day or $4.75 per hog production space per
year in a continuous production system.
A study on TGE calculated losses at $1.49 per hog in infected herds (Miller
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and Kliebensteln, 1985), It was $0.18 per hog when averaged over all herds.
A program that reduced TGE losses from $0.18 to $0.09 per head would reduce
production costs by $7.2 million annually.
Johne's Analysis A study of Johne's (Paratuberculosls) disease in a dairy herd
shows that method of control can have a dramatic impact oh number of cows
infected (Walker). This is shown in Table 5. The model developed was an
epidemiologic-economic simulation of a dairy herd over 30 years. Johne's disease
and selected control alternatives were Incorporated into a dynamic interactive
approach. The Initial herd level prevalence rate when first diagnosed had an
impact on effective control alternatives. Vaccination or fecal culture testing
were effective control devices when the initial prevalence rate was low.
Alternatively, when the prevalence rate was high (12 percent or higher) both
fecal culture testing and vaccination were needed to gain quick disease control.
Johnes disease costs increase as disease level increases. At low
prevalence levels the impact is minor. For a 6 percent Initial prevalence rate,
if specific disease control practices were not implemented, the decline in
discounted (10%) returns to labor and management was less than $40 per year.
This was for an 80 cow herd. Labor and management returns fell by about $1,800
per year for an initial prevalence rate of 12 percent. This compared to a $4,000
per year decline at the 28 percent initial prevalence. '
Johne's disease can have an interactive effect on long run herd milk
production. If disease is not present or at lower levels, cull rates are lower
and cows have a greater chance of remaining within the herd until after they
reach peak production and lactation production potential begins to decline.
During this time heifer sales may increase if heifer replacements are not needed
in the milking herd. This points out the importance of using the heifer pool
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wisely and economically. It should be noted that this Interactive effect Is
generally limited to low disease prevalence rates such as 6 percent. For higher
prevalence rates, the Increased number of Infected cows prohibits producers from
being as selective in choosing which replacement heifers to bring Into the herd.
All replacement heifers may be needed and a younger lower producing herd results.
Losses Increase as level of control effectiveness decline. This Is shown
In Table 6. While this should not be too revealing, there are some Interesting
relationships In Table 6. If there Is a control that is highly effective and
cost efficient the need to start an early control program is lowered. For
example, with a control program that is 90 percent effective the discounted
returns are the same with an initial prevalence rate of 6 or 12 percent. For
diseases which have low efficiency of control the need for information on disease
prevalence is heightened. Discounted return decline dramatically. This points
to the need for improved disease diagnosis. It offers the benefit quicker action
against disease. Additionally, it can reduce risks from disease and enhance the
potential for disease control strategies rather than the disease prevention
approach.
SUHHART
Biotechnology offers much for development of a more sustainable
agriculture. Benefits of an effective and sustainable technology are quite
diverse and far ranging. They range from producers to consumers, agribusiness
firms and government agencies. It must also be recognized that some products
have both benefits and costs associated with their use. Some may reduce problems
while increasing another. Thus, wise and prudent use is needed in both
development and use of blotechnologiec products.
As with many new technologies there are no clear answers on the products
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Impacts on the environment and society. None-the-less, potential Impacts need
to be analyzed to determine likely scenarios. The potential for catestrophlc
outcomes needs to be realized with an assessment of the heed for society to bear
risks that may provide low benefits properly evalxiated. Socially optimal disease
control measures must take Into account all costs and benefits - the direct as
well as Indirect or external.
Decisions on producer adoption of animal disease control techniques will
Involve a number of factors. These include management Intensity, Information
availability, financing, production systems, and available resources. These
factors are not uniform across producers and thus sharing of benefits and costs
will not likely be uniform. Animal disease control strategies are not
necessarily products that will transform below average managers into above
average managers.
For effective and efficient adoption of these biotechnologies programer
aimed at development and nurturing intensive management are needed,
identification of management strategies which accompany the products are needed.
A sample of cost analysis of selected diseases shows that economic analysis
of animal disease control alternatives is an Important component of disease
control policies. These costs need to be evaluated at the producer as well as
societal level.
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Table 1. Percentage of Herds and Animals with Positive Titters for Disease
NAHMS
% of Herds % of Total
Positive Animal Positive Disease
Transmissible gastroenteritis 52 24
Mycoplasma hyopneumonla 70 43
Hemophllus pleuroneumonlae 89 47
Pseudorabies 15 7
Porcine parvovirus 92 68
Swine influenza 70 43
Eperythrozoenosla 19 3
Swine dysentery 85 27
Table 2. Valuation of losses due to clinical PR.
Tvne of los.q Cost
Term abortion $348.66
Abortion at 3 months 340.14
Stillborn or mummified pig 37.20
Death of a baby pig 47.63
Death of growers/finishers 56.90
Open at 60 days (sow sold) 308.97
Open at 60 days (sow rebred) 103.98
Open at 30 days (sow sold) 231.50
Open at 30 days (sow rebred) - 39.16
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Table 5, Number of Cows Infected with Johnes for Selected Control Strategies
Initial Prevalence <
Rate Level of Vaccine Effectiveness
90 50 10
VACCINATION
6 15 15 127
12 33 70 259
20 57 110 289
VACCINATION AND FECAL CULTURE TEST
6 12 17 31
12 13 19 44
20 13 19 53
Table 6. Discounted Returns for Vaccination Strategy By Prevalence Rate and
Vaccination Effectiveness Level (1)
Initial Prevalence
Rate Level of Vaccine Effectiveness
90 50 10
6 $379,272 $371,273 $368,278
12 $379,272 $350,484 $347,470
20 $360,559 $334,191 $331,703
(1) Discount rate is 10 percent.
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